Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $96,165 - $154,710
-4,500 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$12.98 - $30.25 $58,410 - $136,125
4,500 New
4,500 $70,000
Q4 2019

Feb 14, 2020

SELL
$18.89 - $31.89 $354,093 - $597,778
-18,745 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$20.88 - $25.66 $438,480 - $538,860
-21,000 Reduced 52.84%
18,745 $407,000
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $41,040 - $52,900
-2,000 Reduced 4.79%
39,745 $1 Million
Q1 2019

May 13, 2019

SELL
$20.23 - $26.29 $10,115 - $13,145
-500 Reduced 1.18%
41,745 $1.03 Million
Q4 2018

Feb 14, 2019

BUY
$17.64 - $28.32 $674,641 - $1.08 Million
38,245 Added 956.12%
42,245 $780,000
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $82,560 - $102,680
4,000 New
4,000 $103,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.57B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.